PPT-The Diabetic Retinopathy Clinical Research Network

Randomized Clinical Trial Evaluating Intravitreal Ranibizumab or Intravitreal Saline for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy Supported through a cooperative agreement from the National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Department of Health and Human Services EY14231 EY14229 EY018817 . Carmen . Leyva. . Vicki Herrin . Hampton Huddleston. Stephen F. Austin State University. What is Macular Degeneration?. Macular Degeneration is the progressive deterioration of the macula, the light-sensitive cells of the central retina, at the back of the eye. As the macular cells malfunction and die, central vision becomes gray, distorted and is eventually lost. Peripheral vision does not become affected. . Faculty of medicine. Ophthalmology department. Diabetic Retinopathy. Supervisor Dr.Mohammed Ramadan. Done by:. Alaa' Mohammed al.Gharib…..1102. Amany Zohair Tabash………...1103. Abbas Waleed Iter…..............…1104. Nissen. , . Cydney. Williams. Diabetic Retinopathy. What is diabetic retinopathy?. Diabetic retinopathy is a complication of diabetes that occurs when the disease damages tiny blood vessels inside the retina. Elevated levels of blood glucose harm these blood vessels, usually causing blindness in both eyes.. Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. Ayesha S Abdullah. 28.12.2012. Learning outcomes. By . the end of the lecture the students would be able . to;. Describe the epidemiology of DR. Correlate the pathogenesis of DR with the clinical . presentation . David Kinshuck. Associate specialist ophthalmology Good Hope . &. www.diabeticretinopahty.org.uk. Diabetic retinopathy in . pregnancy. What is diabetic retinopathy. Mechanisms. Identification..screening. MALAWI. Population :15,900,000. Gross national income per capita: 730. Life expectancy at birth m/f (years,2012): 58/60. Infant mortality rate: 40.1 deaths/1,000 live births. Health Staffing. 2 . P. hysicians . Diana V Do, Xue Wang, Satyanarayana S Vedula, Michael Marrone, Gina Sleilati, Barbara S Hawkins, Robert N Frank. Issue 1, 2015. A presentation to:. Meeting name. Date. Table of Contents. 01. Background. Improving Diabetic Retinopathy Screening in the Outpatient Primary Care Setting. Melissa Prado, MD, MSc. Audy Whitman, MD, MSc. Pitt County, NC . Diabetic Population: . 9.9%. of all adults over 20 years old; . Introduction About Myself. 2. 25-Nov-15. Saraswathi. Completed . M.Sc., M.Phil., M.C.A. Doing . PhD[II Year] in Bharathiar University-Part Time. Assistant Professor in Nehru Memorial College. 3. Differentialdiagnosesincludeconditionssuchhypertensiveretinopathy,retinalarterialmacroaneuysmCoatsdiseaseandchoroidalneovascularisation CWS Fluid in ONL HEx Blot haemorrhage Diabeticretinopathy(DR)ret 1 Diabetic Retinopathy Guidelines December 2012 Scientific Department The Royal College of Ophthalmologists 17 Cornwall Terrace Regent’s Park London NW1 4QW Telephone: 020 7935 0702 Facsimile: 020 7 José Estevez. 18/08/2018. I would . like to acknowledge the Kaurna people who are the traditional custodians of this land and that we respect their spiritual relationships with their country.. I would .